Drugmakers are lobbying Trump to phase in tariffs on imported pharmaceutical products in hopes of reducing the sting from the ...

Europe's pharmaceutical sector is bracing for the potential impact of U.S. tariffs as hopes of an industry-wide exemption by ...

Concerns about potential pharma tariffs began before Trump took office after he repeatedly threatened a 25% tariff.

US President Donald Trump has again singled out Ireland's pharmaceutical industry as a target for tariffs. Trump was speaking ...

Many investor eyes were on the pharmaceutical industry on Tuesday, and not necessarily for the right reasons. The Trump ...

Siemens partners with Miko Pharma to develop cutting-edge pharmaceutical manufacturing facilities in Ghana. The agreement ...

Leerink Partners analyst David Resinger warned his clients on Sunday that the tariff risks to the industry are ...

Tariffs are one way for Donald Trump to achieve tax cuts, and Irish-based pharma industry may be a golden goose ready for ...

The talks between the administration and the industry, which have been taking place behind closed doors, have given some ...

Plenty of money changed hands in pharma M&A during March, with the biggest deal a $6.7 billion merger between Mallinckrodt ...

Drugmakers are lobbying President Trump to phase in tariffs on imported pharmaceutical products to alleviate the impact and ...

Pfizer in 2019 sold $20 billion of drugs in the U.S. Its federal tax bill? Zero. That revelation was part of a Senate Finance ...